Introduction to precision medicine

Precision medicine is a personalized diagnosis and treatment method based on big data, which has a wide range of applications.

The content of precision medicine in different countries is not exactly the same. For example, the American version of Precision Medicine emphasizes the collection and analysis of comprehensive data of residents, the British version emphasizes the collection of clinical data, and China emphasizes the maximization of benefits. Although there are different interpretations of precision medicine in the world, the definition of precision medicine in various countries includes diagnosis and treatment methods based on big data, which has a wider application range and emphasizes personalization and differentiation.

Policies to guide and support the development of precision medical industry

Judging from the political and legal environment of the global precision medical industry, many countries around the world have launched development plans related to precision medical care to encourage and support the development of precision medical industry. Representative projects include Britain (100,000-person genome project), the United States ("All of us" research project) and Australia (healthy future mission of genomics).

Gene sequencing technology, cell and gene therapy technology continue to develop.

From the dideoxynucleotide termination method invented by Sanger in 1970s to the chemical degradation method invented by Gilbert and maxam as the first generation sequencing technology, so far, the development of gene sequencing technology has given birth to four generations of sequencing technology. At present, the mainstream of the market is the second generation sequencing technology, and the typical representatives are Solexa technology of Illumina company, 454 technology of Roche company and Life.

Tech's solid technology. In recent years, the third-generation technology and the fourth-generation nano-hole sequencing technology, represented by single molecule sequencing technology of Heloscope and SMRT technology of PacBio, have appeared one after another, marking the future development direction of sequencing technology.

The research and production of cell and gene therapy (CGT) mainly includes three processes: plasmid production, virus production and T cell preparation. The related technologies of cell and gene therapy in the world can be divided into cell therapy technology and gene therapy technology, as shown in the following table. At present, cell and gene therapy is developing from traditional cell therapy to combination with gene therapy.

Overview of the development environment of global precision medical industry

From the perspective of policy environment, many countries around the world have launched development plans related to precision medicine to encourage, support and guide the development of precision medicine industry; From the technical environment, the emergence of the fourth generation sequencing technology and gene therapy technology laid the foundation for the development of the industry. Generally speaking, policies and technologies promote the development of the industry.

For more research and analysis of this industry, please refer to the analysis report of Global Precision Medical Industry Development Prospect Forecast and Investment Strategic Planning of Prospective Industry Research Institute.